Senior R&D leader with 15+ years of experience spanning drug discovery, in vivo pharmacology and disease models, translational and nonclinical development, and advanced therapeutic modalities. Built scientific capabilities and multidisciplinary teams and guided programs from platform innovation and candidate selection through IND-enabling development and regulatory interactions. Combines deep expertise in genetic medicines with broad drug-development leadership, portfolio management, external innovation and cross-functional decision making.
CORE EXPERTISE
R&D Leadership: Portfolio & program strategy | Candidate & technology decisions | People & capability building
Drug Development: Discovery-to-IND translation | Translational & nonclinical development | In vivo pharmacology & disease models
Advanced Modalities: Cell therapy | Gene therapy | Genome editing | Biologics & Oligonucleotide therapeutics (mRNA / siRNA / ASO) | viral and non-viral delivery systems
Therapeutic Areas: all
Director
Roberto Nitsch
I am a senior pharmaceutical R&D leader with extensive experience in biotechnology, genome editing, advanced therapeutics, and drug development. I combine deep scientific expertise with strategic thinking, cross-functional leadership, and a strong ability to translate complex science into actionable decisions. I am passionate about innovation, solving challenging problems, and helping organizations turn technologies into meaningful opportunities
AstraZeneca
LinkedIn profileAreas of expertise
- Cell and Gene Therapy
- Pipeline and portfolio strategy
- Research and Development
